Free Trial

Hinge Health (NYSE:HNGE) Shares Gap Down - Here's What Happened

Hinge Health logo with Medical background

Key Points

  • Hinge Health's stock price gapped down significantly from $59.03 to $52.00 before opening at $53.70, reflecting a notable market reaction.
  • Analyst ratings for Hinge Health have generally been positive, with 15 analysts rating it as a Buy and a consensus price target of $55.71.
  • Several hedge funds have recently acquired substantial new positions in Hinge Health, indicating increased institutional interest in the stock.
  • Want stock alerts on Hinge Health? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Shares of Hinge Health Inc. (NYSE:HNGE - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $59.03, but opened at $52.00. Hinge Health shares last traded at $53.70, with a volume of 820,429 shares.

Wall Street Analyst Weigh In

HNGE has been the subject of several research reports. Piper Sandler initiated coverage on shares of Hinge Health in a research note on Monday, June 16th. They set an "overweight" rating and a $41.00 price target for the company. Morgan Stanley raised their price target on shares of Hinge Health from $46.00 to $57.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 6th. KeyCorp raised their price target on shares of Hinge Health from $45.00 to $60.00 and gave the stock an "overweight" rating in a research note on Monday, July 14th. Evercore ISI raised their price target on shares of Hinge Health from $50.00 to $60.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. Finally, Citigroup initiated coverage on shares of Hinge Health in a research note on Monday, July 14th. They set an "outperform" rating for the company. One analyst has rated the stock with a Strong Buy rating and fifteen have assigned a Buy rating to the company's stock. According to MarketBeat, Hinge Health has an average rating of "Buy" and a consensus price target of $55.71.

Check Out Our Latest Research Report on HNGE

Hinge Health Stock Performance

The company's 50 day simple moving average is $46.63.

Hedge Funds Weigh In On Hinge Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Atika Capital Management LLC bought a new position in Hinge Health during the second quarter worth $2,261,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Hinge Health during the second quarter worth $966,000. Foresite Capital Management VI LLC acquired a new stake in shares of Hinge Health during the second quarter worth $6,986,000. Ensign Peak Advisors Inc acquired a new stake in shares of Hinge Health during the second quarter worth $16,172,000. Finally, Greenland Capital Management LP acquired a new stake in shares of Hinge Health during the second quarter worth $273,000.

Hinge Health Company Profile

(Get Free Report)

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines